Status:
TERMINATED
Aerobic Exercise in Patients Receiving Chemotherapy for Cancer
Lead Sponsor:
Wake Forest University Health Sciences
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Cardiac Toxicity
Chemotherapeutic Agent Toxicity
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
RATIONALE: Aerobic exercise may help prevent side effects caused by chemotherapy and help improve heart health. PURPOSE: This randomized clinical trial is studying the side effects of aerobic exercis...
Detailed Description
OBJECTIVES: * To determine if patients with cancer can exercise safely and routinely, under supervision, while receiving anthracycline chemotherapy. * To determine the magnitude of the change in the ...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Patients with cancer scheduled to receive 4-6 courses of an anthracycline-based chemotherapy
- PATIENT CHARACTERISTICS:
- Able to pedal a stationary bicycle
- No severe hypertension (systolic blood pressure \> 220 mm Hg or diastolic blood pressure \>120 mm Hg)
- No atrial fibrillation with an uncontrolled ventricular response
- No ventricular arrhythmias
- No unstable angina
- No acute myocardial infarction within the past 28 days of enrollment
- No severe valvular heart disease
- No severe (exercise-limiting) peripheral vascular disease
- No severe pulmonary disease
- PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Exclusion
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT00728429
Start Date
June 1 2008
End Date
May 1 2009
Last Update
May 30 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest University Comprehensive Cancer Center
Winston-Salem, North Carolina, United States, 27157-1096